5 hours Aytu BioPharma, Inc. (NASDAQ:AYTU) Q4 2024 Earnings Call Transcript Insider Monkey

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q4 2024 Earnings Call Transcript September 26, 2024 Aytu BioPharma, Inc. misses on earnings expectations. Reported EPS is $-0.82 EPS, expectations were $-0.45. Operator: Greetings, welcome to the Aytu BioPharma’s Fiscal 2024 Q4 Earnings Call. At this time, all participants have been placed on a listen-only mode. [Operator Instructions] Please note […]

·